(Q45238630)

11 December 2017

title

Disruption of mineralocorticoid receptor function increases corticosterone responding to a mild, but not moderate, psychological stressor (English)

1 reference

11 December 2017

Thaddeus W W Pace

1

1 reference

11 December 2017

Robert L Spencer

series ordinal

2

1 reference

11 December 2017

publication date

25 January 2005

1 reference

American Journal of Physiology - Endocrinology and Metabolism

11 December 2017

published in

1 reference

11 December 2017

volume

288

1 reference

11 December 2017

issue

6

1 reference

11 December 2017

page(s)

E1082-8

1 reference

The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00521.2004

Activated type II receptors in brain cannot rebind glucocorticoids: relationship to progesterone's antiglucocorticoid actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00521.2004

Antimineralocorticoid canrenoate enhances secretory activity of the hypothalamus-pituitary-adrenocortical (HPA) axis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00521.2004

Regulation of adrenocorticosteroid receptor mRNA expression in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00521.2004

Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00521.2004

Rapid corticosteroid-dependent regulation of mineralocorticoid receptor protein expression in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00521.2004

Corticosteroid Inhibition of ACTH Secretion*

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00521.2004

Evaluation of RU28318 and RU40555 as selective mineralocorticoid receptor and glucocorticoid receptor antagonists, respectively: receptor measures and functional studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00521.2004

Obese Zucker rats have reduced mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 1 expression in hippocampus-implications for dysregulation of the hypothalamic-pituitary-adrenal axis in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00521.2004

Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00521.2004

Regulation of HSP90 and corticosteroid receptor mRNA by corticosterone levels in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00521.2004

Pathways to the secretion of adrenocorticotropin: a view from the portal*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00521.2004

On the Role of Brain Mineralocorticoid (Type I) and Glucocorticoid (Type II) Receptors in Neuroendocrine Regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00521.2004

Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00521.2004

Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00521.2004

Diurnal differences in basal and acute stress levels of type I and type II adrenal steroid receptor activation in neural and immune tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00521.2004

Adrenal steroid type I and type II receptor binding: estimates of in vivo receptor number, occupancy, and activation with varying level of steroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00521.2004

Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00521.2004

10.1152/AJPENDO.00521.2004

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference